Urgent: Hydroxycut Suits Have Recently Been Reported
On May one, 2009, there had been a recall of fourteen Hydroxycut diet-aid products stemming from a number of reports that people using the products were developing significant liver issues and other health concerns. Less than seven days later, on May 4, the first Hydroxycut class action lawsuit was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Settlements alleges company failure in informing the public about potential dangers of the products. Naturally, it’s too soon to grasp the suit is going to turn out, but if the company had information which it didn’t divulge to customers, it should definitely be held accountable.
A class action lawsuit is filed by a group of folks, all of whom have similar claims against a certain company. Filing a class action is just as effective, and much less expensive, than filing an individual suit. As a rule, filing a class action lawsuit won’t cost you anything unless there’s a settlement. At that point, the lawyer who handled the suit will take his charges from the compensation that was awarded and then distribute the leftover funds to the accusers in the case. Since this is the case, you will be ready to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is an example of the reasons that class action lawsuits have become so popular.
The 1st class action suit against Iovate was filed in Canada where the company is found and represents all Canadian citizens who sustained health problems due to Hydroxycut products. The FDA recall happened in the U. S. where 23 cases of liver disorders and other health problems had been reported. Health Canada failed to receive any reports of liver damage caused by the diet products, but they did receive seventeen reports concerning folks who sustained respiratory, neurological, heart, and gut problems as a consequence of Canadians using the products.
The Hydroxycut Settlement Suit alleges the company sold the products without correctly informing the general public of the health risks that they could exposing patrons to. The complaint states the company failed to publish the data on the product labels saying that users could run the chance of liver and kidney damage as well as stomach, heart, respiration, and neurological problems. The suit goes on to claim this was an obvious omission on the part of the company which deliberately misled buyers concerning the security of the products.
